About

Heart failure (HF) is a rapidly growing public health issue with an estimated prevalence of >37.7 million individuals globally. HF is a shared chronic phase of cardiac functional impairment secondary to many aetiologies, and patients with HF experience a range of symptoms that affect their quality of life, including dyspnoea, fatigue, poor exercise tolerance and fluid retention.

The burden of HF will continue to rise, due to population aging, population growth and improved treatment of HF and other cardiovascular disorders. As a result, clinicians will be increasingly challenged to develop treatment plans and care systems that reduce the high levels of morbidity and mortality experienced by these patients, both from their HF and other comorbidities.

Articles

Cardiac Transthyretin-derived Amyloidosis: An Emerging Target in Heart Failure with Preserved Ejection Fraction?

Citation:

Cardiac Failure Review 2020;6:e21.

Transcriptomic Research in Heart Failure with Preserved Ejection Fraction: Current State and Future Perspectives

Citation:

Cardiac Failure Review 2020;6:e24.

Heart Failure With Mid-range or Recovered Ejection Fraction: Differential Determinants of Transition

Citation:

Cardiac Failure Review 2020;6:e28.

Pulmonary Hypertension in Heart Failure Patients

Citation:

Cardiac Failure Review 2020;6:e05.